We are live on
!
Find out more
RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$810M
1-Year Est. Return
30.2%
This Fund
S&P 500
This Quarter
Est. Return
+4.94%
1 Year Est. Return
+30.2%
3 Year Est. Return
+116.38%
5 Year Est. Return
+153.13%
10 Year Est. Return
+962.25%
AUM
$977M
AUM Growth
+$166M
(+20%)
Cap. Flow
+$154M
Cap. Flow
% of AUM
15.75%
Top 10 Holdings %
Top 10 Hldgs %
25.96%
Holding
96
New
4
Increased
44
Reduced
31
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nektar Therapeutics
NKTR
|
+$31.5M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$16.4M |
| 3 |
Incyte
INCY
|
+$15.4M |
| 4 |
SGMO
SANGAMO THERAPEUTICS INC
SGMO
|
+$13.2M |
| 5 |
AET
Aetna Inc
AET
|
+$12.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$13.4M |
| 2 |
Biogen
BIIB
|
+$8.24M |
| 3 |
CELG
Celgene Corp
CELG
|
+$7.12M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
+$5.83M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$5.72M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 91.68% |
| 2 | Financials | 1.43% |
| 3 | Energy | 0.15% |
| 4 | Technology | 0.13% |
| 5 | Communication Services | 0.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
JPMorgan Chase
JPM
$950B
| $441K | 0.05% |
4,235
-1,156
| -21% | -$127K |
|
77
Halliburton
HAL
$26.6B
| $415K | 0.04% |
9,221
-5,438
| -37% | -$271K |
|
78
Qualcomm
QCOM
$176B
| $407K | 0.04% |
7,247
-805
| -10% | -$44.9K |
|
79
AB InBev
BUD
$165B
| $382K | 0.04% |
3,788
-421
| -10% | -$41.8K |
|
80
Walt Disney
DIS
$181B
| $365K | 0.04% |
3,483
-1,130
| -24% | -$116K |
|
|
JHG
81
DELISTED
Janus Henderson
JHG
| $363K | 0.04% |
11,828
-6,031
| -34% | -$193K |
|
82
Ford
F
$55.7B
| $359K | 0.04% |
32,405
-10,201
| -24% | -$117K |
|
83
IBM
IBM
$224B
| $344K | 0.04% |
2,574
-1,373
| -35% | -$191K |
|
|
RGLS
84
DELISTED
Regulus Therapeutics
RGLS
| $325K | 0.03% |
4,107
| – | – |
|
85
Wells Fargo
WFC
$264B
| $325K | 0.03% |
5,858
| – | – |
|
86
Pfizer
PFE
$153B
| $318K | 0.03% |
9,227
| – | – |
|
87
Microsoft
MSFT
$3.71T
| $285K | 0.03% |
2,887
-2,578
| -47% | -$250K |
|
88
Gen Digital
GEN
$17.5B
| $261K | 0.03% |
12,635
-1,404
| -10% | -$33.7K |
|
89
Alphabet (Google) Class A
GOOGL
$4.33T
| $201K | 0.02% |
+3,560
| New | +$194K |
|
90
STAAR Surgical
STAA
$1.21B
| – | – |
-24,658
| Closed | -$365K |
|
|
LUMO
91
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| – | – |
-20,116
| Closed | -$1.31M |
|
|
EPZM
92
DELISTED
Epizyme, Inc
EPZM
| – | – |
-181,291
| Closed | -$3.22M |
|
|
RARX
93
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| – | – |
-39,115
| Closed | -$208K |
|
|
DERM
94
DELISTED
Dermira, Inc.
DERM
| – | – |
-95,000
| Closed | -$759K |
|
|
ELGX
95
DELISTED
Endologix Inc
ELGX
| – | – |
-90,600
| Closed | -$3.83M |
|
|
KERX
96
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| – | – |
-302,157
| Closed | -$1.24M |
|
Similar funds
PS
ACM
AR
KCP
BCM
RIM
GCM
CL
Rhenman & Partners Asset Management's Q2 2018 Portfolio in Review
As of Q2 2018, Rhenman & Partners Asset Management held 96 positions worth $977M, up 20% from $811M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Rhenman & Partners Asset Management deployed $154M of net new capital in Q2 2018, opening 4 new positions and adding to 44 existing holdings. Its largest new stake was Aetna Inc: 70,000 shares worth $12.8M.
By sector, the portfolio is most concentrated in Healthcare at 92% of assets, down from 95% a quarter earlier, followed by Financials and Energy.
On the sell side, the largest reduction was AbbVie, an estimated $13.4M trimmed.
- Rhenman & Partners Asset Management's largest Q2 2018 buy was Aetna Inc: 70,000 shares worth $12.8M.
- Rhenman & Partners Asset Management added most to Nektar Therapeutics in Q2 2018, an estimated $31.5M increase.
- Rhenman & Partners Asset Management's biggest Q2 2018 reduction was AbbVie, cutting an estimated $13.4M.
- Rhenman & Partners Asset Management fully exited Endologix Inc in Q2 2018, selling an estimated $3.83M.
- Rhenman & Partners Asset Management's ten largest holdings make up 26% of its $977M portfolio in Q2 2018.
- Rhenman & Partners Asset Management opened 4 new positions and closed 7 in Q2 2018.
- Rhenman & Partners Asset Management's portfolio value rose 20% quarter-over-quarter to $977M.
Based on Rhenman & Partners Asset Management's 13F filing for Q2 2018, filed 20 Jul 2018.